CRON vs. USNA, CGC, MNMD, ACB, BTMD, MNKD, VIR, ABCL, SRRK, and PRTA
Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include USANA Health Sciences (USNA), Canopy Growth (CGC), Mind Medicine (MindMed) (MNMD), Aurora Cannabis (ACB), biote (BTMD), MannKind (MNKD), Vir Biotechnology (VIR), AbCellera Biologics (ABCL), Scholar Rock (SRRK), and Prothena (PRTA). These companies are all part of the "medical" sector.
USANA Health Sciences (NYSE:USNA) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, community ranking, institutional ownership, earnings, analyst recommendations, valuation and dividends.
54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.3% of USANA Health Sciences shares are held by insiders. Comparatively, 2.0% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Cronos Group received 69 more outperform votes than USANA Health Sciences when rated by MarketBeat users. Likewise, 61.21% of users gave Cronos Group an outperform vote while only 60.68% of users gave USANA Health Sciences an outperform vote.
USANA Health Sciences currently has a consensus price target of $46.00, indicating a potential upside of 2.06%. Cronos Group has a consensus price target of $2.83, indicating a potential upside of 9.82%. Given USANA Health Sciences' higher probable upside, analysts plainly believe Cronos Group is more favorable than USANA Health Sciences.
USANA Health Sciences has higher revenue and earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.
In the previous week, USANA Health Sciences had 22 more articles in the media than Cronos Group. MarketBeat recorded 25 mentions for USANA Health Sciences and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.43 beat USANA Health Sciences' score of 0.28 indicating that USANA Health Sciences is being referred to more favorably in the media.
USANA Health Sciences has a net margin of 6.88% compared to USANA Health Sciences' net margin of -84.15%. Cronos Group's return on equity of 12.80% beat USANA Health Sciences' return on equity.
USANA Health Sciences has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500.
Summary
USANA Health Sciences beats Cronos Group on 11 of the 18 factors compared between the two stocks.
Get Cronos Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cronos Group Competitors List
Related Companies and Tools
